Intermediate syndrome following acute organophosphate poisoning: Correlation with initial serum levels of muscle enzymes

Basic and Clinical Pharmacology and Toxicology

Volumn 100, Issue 3, 2007, Pages 201-204

  Aygun, Dursun ^a   Erenler, Ali Kemal ^a   Karatas, Aydin Deniz ^a   Baydin, Ahmet ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; MUSCLE ENZYME; ORGANOPHOSPHATE PESTICIDE;

ADOLESCENT; ADULT; AGED; ANTICHOLINERGIC SYNDROME; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE SEVERITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MUSCLE INJURY; PREDICTION; PRIORITY JOURNAL; SAMPLE SIZE;

ACETYLCHOLINESTERASE; ADOLESCENT; ADULT; AGED; ASPARTATE AMINOTRANSFERASES; CREATINE KINASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION; ORGANOPHOSPHORUS COMPOUNDS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SYNAPTIC TRANSMISSION; SYNDROME;

EID: 33847055087     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00042.x     Document Type: Conference Paper

References (21)

1. Aminoff MJ. Effects of occupational toxins on the nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds). Neurology in Clinical Practice. Butterworth & Heinemann, Philadelphia, PA, 2004;1709-18.
2. Aygun, D, Doganay Z, Altintop L et al. Serum cholinesterase and prognosis of acute organophosphate poisoning. J Toxicol Clin Toxicol 2002;40:903- 10.
3. John M, Oommen A, Zachariah A. Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 2003;24:43-53.
4. Karalliedde L, Baker D, Marrs TC. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev 2006;25:1-14.
5. Bohlmeyer TJ, Wu AH, Perryman MB. Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis. Rheum Dis Clin North Am 1994;20:845-56.
6. Areekul S, Srichairat S, Kirdudom P. Serum and red cell cholinesterase activity in people exposed to organophosphate insecticides. Southeast Asian J Trop Med Public Health 1981;12:94-8.
7. Schaumburg HH, Spencer PS. Recognizing neurotoxic disease. Neurology 1987;37:276-8.
8. Namba T, Nolte C, Jackrel J, Grob D. Poisoning due to organophosphate insecticides. Am J Med 1971;50:475-92.
9. Nouira S, Abroug F, Elatrous S. Prognostic value of serum cholinesterase in organophosphate poisoning. Chest 1994;106:1811-4.
10. Besser R, Gutmann L. Intoxication with organophosphorus compounds. In: Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology (Intoxications of the Nervous System; Part 1). Elsevier, Amsterdam, The Netherlands, 1994;151-81.
11. Bardin PG, Van Eeden SF. Organophosphate poisoning: grading the severity and comparing treatment between atropine and glycopyrrolate. Crit Care Med 1990;18:956-60.
12. Preston DC, Shapiro BE, Brooke MH. Proximal, distal, and generalized weakness. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J (eds). Neurology in Clinical Practice. Butterworth & Heinemann, Philadelphia, PA, 2004;367-86.
13. De Bleecker J, Van Den Neucker K, Colardyn F. Intermediate syndrome in organophosphorous poisoning a prospective study. Crit Care Med 1993;21:1706-11.
14. Giltay EJ, van Schaardenburg D, Gooren LJG, Kostense PJ, Dijkmans BAC. Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis. Ann Rheum Dis 1999;58:541-5.
15. Karalliedde L, Senanayake N. Organophosphorus insecticide poisoning. Br J Anesth 1989;63:736-50.
16. Roja R, Shekoufeh N, Mohammad A. Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials. Hum Exp Toxicol 2006;25:57-62.
17. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000;38:47-50.
18. Benso B, Tolo D, Mclntire M. Is intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy? Clin Toxicol 1992;30:347-9.
19. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using metaanalytic techniques. Crit Car Med 2006;34:502-10.
20. Ranjbar A, Solhi H, Mashayekhi FJ, Susanabdi A, Rezaie A, Abdollahi M. Oxidative stress in acute human poisoning with organophosphorus insecticides: a case control study. Environ Toxicol Pharmacol 2005;20:88-91.
21. Dandapani M, Zachariah A, Kavitha MR, Jeyaseelan L, Oommen A. Oxidative damage in intermediate syndrome of acute organophosphorous poisoning. Indian J Med Res 2003;117:253-9.